/
/
/

Venmax Drugs And Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)13.99
Volume (₹)1,002.00
High (₹)13.99
Upper Circuit16.36
Low (₹)13.64
Lower Circuit10.92
Prev Close13.64
52W High (₹)31.49
Price13.64
52W Low (₹)12.51

Share Market Cap & Key Ratios Overview

M.Cap (₹)19.76 Cr
Div. Yield (%)0.00
PE Ratio70.31
Debt to Equity-0.08
Price to Book-22.62
Book Value-1.26
EPS (TTM)0.19
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
VENMAX-XNSE
LTP
1W Low
1W High
Market cap (₹)
1748.3-14.65 (-0.83%)
1720.80
1854.80
4,24,202Cr
9944.5+289.5 (3.00%)
9622.85
10020
2,64,141Cr
4588.75+24.65 (0.54%)
4555
4668.55
1,74,402Cr
2297.5+52.5 (2.34%)
2207.10
2442
1,26,811Cr
1220.1+34.1 (2.88%)
1184.55
1264.20
1,23,685Cr
1347.4+8.9 (0.66%)
1337.30
1390.70
1,11,868Cr
1377.2+20.2 (1.49%)
1360.60
1390
1,11,650Cr
2494+32.8 (1.33%)
2457.35
2527.80
1,02,196Cr
1669.2+14.2 (0.86%)
1650.10
1688.05
96,951Cr
1993.95-4.05 (-0.20%)
1974.05
2032
91,301Cr
13.64+0.67 (5.17%)
12.51
14.30
20Cr

Key Highlights of Venmax Drugs And Pharmaceuticals Ltd Balance Sheet

Venmax Drugs And Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹5.24Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹5.24Cr, and the reserves and surplus of the company is -₹5.9Cr.

The company has its non-current liabilities with total liabilities of ₹5.17Cr as of 2025-03-31.

The current liabilities are ₹75.67Lakh as of 2025-03-31. At the same time, current assets are ₹5.13Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹4.05Lakh, provided in the Venmax Drugs And Pharmaceuticals Ltd financial statements.